As they often have done in the past, the FTC and the FDA issued joint cease and desist letters last week to 10 companies suspected of making unproven health claims – in this instance, claims that dietary supplements treat or cure diabetes. The FTC and the FDA join forces on such letters in order to
More Posts
FDA Rejects CBD New Dietary Ingredient Notifications: Four Practical Takeaways
Dietary Supplement and Personal Care Products Regulatory and Litigation Highlights – May and June 2021
Food Industry Regulatory and Litigation Highlights – June 2021
Food Industry Regulatory and Litigation Highlights – April and May 2021
Dietary Supplement and Personal Care Products Regulatory and Litigation Highlights – April 2021
FTC Files First Case Seeking Civil Penalties For Allegedly Deceptive COVID-19 Advertising
Food Industry Regulatory and Litigation Highlights – March 2021
Dietary Supplement and Personal Care Product Regulatory and Litigation Highlights – March 2021
FDA Enforcement: There’s Nothing Inactive About CBD and “FDA Registered” Is Misleading
Subscribe: Subscribe via RSS
Firm/Org